Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes
The DOI matches its Crossref record; 55 of the 56 references it cites were found in a registry or an index.
Abstract
Transfection of embryo fibroblasts by a human ras oncogene does not convert them into tumour cells unless the fibroblasts are established and immortalized before transfection. The embryo fibroblasts become tumorigenic if a second oncogene such as a viral or cellular myc gene or the gene for the polyoma large-T antigen is introduced together with the ras gene.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“However, transformation of primary cells by ras requires either a cooperating oncogene or the inactivation of tumor suppressors such as p53 or p16.”
From Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a (1997) · cites this paper as Land et al. 1983
In the citing paper
“ras cooperates, however, with certain other oncogenic alterations to transform primary rodent cells (Land et al. 1983; Ruley 1983), including overexpression of c-Myc, dominant negative p53, D-type cyclins, and Cdc25A and -B, and loss of p53, p16, or IRF-1”
From Oncogenic ras provokes premature cell senescence associated with accumulation of p53 and p16INK4a (1997) · cites this paper as Land et al. 1983
In the citing paper
“In that setting, dysfunctional telomeres induced a strong cellular senescence phenotype in the emerging lymphomas resulting in potent suppression of lymphomagenesis.”
From Telomeres and telomerase in cancer (2010) · cites this paper as [93]
Citations
Cites
A new technique for the assay of infectivity of human adenovirus 5 DNA
Graham, F. L., & van der Eb, A. J. (1973) · Virology · doi:10.1016/0042-6822(73)90341-3 · Cited by 9,451
Dalla-Favera, R., Bregni, M., Erikson, J., Patterson, D., Gallo, R. C., & Croce, C. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.24.7824 · Cited by 1,773
Mutation selection and the natural history of cancer
Cairns, J. (1975) · Nature · doi:10.1038/255197a0 · Cited by 1,582
Activation of a cellular onc gene by promoter insertion in ALV-induced lymphoid leukosis
Hayward, W. S., Neel, B. G., & Astrin, S. M. (1981) · Nature · doi:10.1038/290475a0 · Cited by 1,567
Taub, R., Kirsch, I., Morton, C., Lenoir, G., Swan, D., Tronick, S., Aaronson, S., & Leder, P. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.24.7837 · Cited by 1,422
Mechanism of activation of a human oncogene
Tabin, C. J., Bradley, S. M., Bargmann, C. I., Weinberg, R. A., Papageorge, A. G., Scolnick, E. M., Dhar, R., Lowy, D. R., & Chang, E. H. (1982) · Nature · doi:10.1038/300143a0 · Cited by 1,393
Self-citationRuley, H. E. (1983) · Nature · doi:10.1038/304602a0 · Cited by 1,248
Mulligan, R. C., & Berg, P. (1981) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.78.4.2072 · Cited by 982
Human EJ bladder carcinoma oncogene is homologue of Harvey sarcoma virus ras gene
Parada, L. F., Tabin, C. J., Shih, C., & Weinberg, R. A. (1982) · Nature · doi:10.1038/297474a0 · Cited by 944
Self-citationDer, C. J., Krontiris, T. G., & Cooper, G. M. (1982) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.79.11.3637 · Cited by 800
Research works printed but not linked: 9
- Berenblum, I. & Shubik, P. Br. J. Cancer 1, 388 (1947).
- Emmelot, P. & Scherer, E. Cancer Res. 37, 1702–1708 (1977).
- Crawford, B. D., Barrett, J. C. & Ts'o, P. O. P. Molec. cell. Biol. 3, 931–945 (1983). · doi:10.1128/mcb.3.5.931
- Murray, M. J. et al. Cell (in the press).
- Aaronson, S. A. & Todaro, G. J. J. Cell Biol. 72, 141–148 (1968).
- Perucho, M., Hanahan, D. & Wigler, M. Cell 22, 309–317 (1980). · DOI · Paper page
- Beard, J. W. in Viral Oncology (ed. Klein, G.) 55–88 (Raven, New York, 1980).
- Adams, J. M., Gerondakis, S., Webb, E., Corcoran, L. & Cory, S. Proc. natn. Acad. Sci. U.S.A. (in the press).
- Gross, L. Oncogenic viruses, 931 (Pergamon, Oxford, 1970).
Cited by
Items 101–200 of 1,010
CDC25 Phosphatases as Potential Human Oncogenes
Galaktionov, K., Lee, A. K., Eckstein, J., Draetta, G., Meckler, J., Loda, M., & Beach, D. (1995) · Science · doi:10.1126/science.7667636 · Cited by 504
Nicolson, G. L. (1987) · PubMed · Cited by 502
Proteins encoded by the human c-myc oncogene: differential expression in neoplastic cells.
Hann, S. R., & Eisenman, R. N. (1984) · Molecular and Cellular Biology · doi:10.1128/mcb.4.11.2486 · Cited by 495
Extreme instability of myc mRNA in normal and transformed human cells.
Dani, C., Blanchard, J. M., Piechaczyk, M., El Sabouty, S., Marty, L., & Jeanteur, P. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.22.7046 · Cited by 516
Tanaka, N., Ishihara, M., Kitagawa, M., Harada, H., Kimura, T., Matsuyama, T., Lamphier, M. S., Aizawa, S., Mak, T. W., & Taniguchi, T. (1994) · Cell · doi:10.1016/0092-8674(94)90132-5 · Cited by 491
Dose-dependent oncogene-induced senescence in vivo and its evasion during mammary tumorigenesis
Sarkisian, C. J., Keister, B. A., Stairs, D. B., Boxer, R. B., Moody, S. E., & Chodosh, L. A. (2007) · Nature Cell Biology · doi:10.1038/ncb1567 · Cited by 490
“(e) Immunofluorescence microscopy of phospho-Akt (reflecting activation of the PI(3)K pathway) and cyclin D1 (reflecting activation of the AP1 pathway) in MTB–TRAS mice induced for 48 h with 2.”
MethodCoppola, J. A., & Cole, M. D. (1986) · Nature · doi:10.1038/320760a0 · Cited by 503
Transgenic mice harboring SV40 t-antigen genes develop characteristic brain tumors
Brinster, R. L., Chen, H. Y., Messing, A., van Dyke, T., Levine, A. J., & Palmiter, R. D. (1984) · Cell · doi:10.1016/0092-8674(84)90367-2 · Cited by 483
“…from the transformation assays involving viral infection (Tooze, 1980; Cooper, 1982; Bishop, 1983) or DNA transfection of established cell lines (Shih et al., 1981; Krontiris and Cooper, 1981; Perucho et al., 1981; Pulciani et al., 1982) or primary cell lines (Land et al., 1983; Ruley, 1983).”
BackgroundMyc and Ras collaborate in inducing accumulation of active cyclin E/Cdk2 and E2F
Leone, G., DeGregori, J., Sears, R., Jakoi, L., & Nevins, J. R. (1997) · Nature · doi:10.1038/387422a0 · Cited by 468
Holt, J. T., Redner, R. L., & Nienhuis, A. W. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.2.963 · Cited by 464
“genes in growth control is the observation that their mutated forms produce dysregulated growth in vitro, such as immortalization, which can be assayed by transformation of primary embryo fibroblasts in cooperation with activated ras oncogenes (29, 33, 42, 48), and in vivo, such as in tumors in transgenic mice (1, 33,…”
BackgroundThe Pathogenesis of Burkitt's Lymphoma
(1990) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60470-4 · Cited by 466
The myc Oncogene: arvelouslomplex
(2002) · Advances in Cancer Research · doi:10.1016/s0065-230x(02)84004-0 · Cited by 463
Deconstructing Stem Cell Tumorigenicity: A Roadmap to Safe Regenerative Medicine
Knoepfler, P. S. (2009) · Stem Cells · doi:10.1002/stem.37 · Cited by 456
Ras Enhances Myc Protein Stability
Sears, R., Leone, G., DeGregori, J., & Nevins, J. R. (1999) · Molecular Cell · doi:10.1016/s1097-2765(00)80308-1 · Cited by 460
NSD2 Links Dimethylation of Histone H3 at Lysine 36 to Oncogenic Programming
Kuo, A. J., Cheung, P., Chen, K., Zee, B. M., Kioi, M., Lauring, J., Xi, Y., Park, B. H., Shi, X., Garcia, B. A., et al. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.08.042 · Cited by 443
“Primarymouse cells can be transformed by two genetic ‘‘hits’’: either loss of a tumor suppressor coupled with activation of an oncogene or activation of two oncogenes (Land et al., 1983).”
BackgroundA putative second cell-derived oncogene of the avian leukaemia retrovirus E26
Leprince, D., Gegonne, A., Coll, J., de Taisne, C., Schneeberger, A., Lagrou, C., & Stehelin, D. (1983) · Nature · doi:10.1038/306395a0 · Cited by 459
High-Intensity Raf Signal Causes Cell Cycle Arrest Mediated by p21 Cip1
Sewing, A., Wiseman, B., Lloyd, A. C., & Land, H. (1997) · Molecular and Cellular Biology · doi:10.1128/mcb.17.9.5588 · Cited by 462
“Moreover, similar to Ras (39, 73), Raf cooperates with other cellular and viral oncogenes, such as the Myc and simian virus 40 large T antigen genes, and has been shown to be transforming in the absence of p53 function in various cell types (3, 26, 46, 54).”
BackgroundSelf-citationDistinct Thresholds Govern Myc's Biological Output In Vivo
Murphy, D. J., Junttila, M. R., Pouyet, L., Karnezis, A., Shchors, K., Bui, D. A., Brown-Swigart, L., Johnson, L., & Evan, G. I. (2008) · Cancer Cell · doi:10.1016/j.ccr.2008.10.018 · Cited by 456
“Individually, Myc or Ras is usually insufficient to drive full tumor progression, but together they exhibit potent oncogenic cooperation (Land et al., 1983).”
BackgroundFunction of a human cyclin gene as an oncogene.
Hinds, P. W., Dowdy, S. F., Eaton, E. N., Arnold, A., & Weinberg, R. A. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.2.709 · Cited by 454
Self-citationTargeted Degradation of Oncogenic KRAS G12C by VHL-Recruiting PROTACs
Bond, M. J., Chu, L., Nalawansha, D. A., Li, K., & Crews, C. M. (2020) · ACS Central Science · doi:10.1021/acscentsci.0c00411 · Cited by 450
“Angew Chem Int Ed Engl 2016, 55 (2), 807-10.”
InfluentialDefinition of regions in human c-myc that are involved in transformation and nuclear localization.
Stone, J., de Lange, T., Ramsay, G., Jakobovits, E., Bishop, J. M., Varmus, H., & Lee, W. (1987) · Molecular and Cellular Biology · doi:10.1128/mcb.7.5.1697 · Cited by 447
“Rat embryo cells (RECs) were harvested and transfected as described previously (36, 37).”
BackgroundMethodMolecular Biology of Burkitt’s Lymphoma
Hecht, J. L., & Aster, J. C. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.21.3707 · Cited by 439
Oncogenic transformation by the tax gene of human T-cell leukemia virus type I in vitro.
Tanaka, A., Takahashi, C., Yamaoka, S., Nosaka, T., Maki, M., & Hatanaka, M. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.3.1071 · Cited by 435
Malignant transformation of early passage rodent cells by a single mutated human oncogene
Spandidos, D. A., & Wilkie, N. M. (1984) · Nature · doi:10.1038/310469a0 · Cited by 457
Phenotypes of c-Myc-deficient rat fibroblasts isolated by targeted homologous recombination.
Mateyak, M. K., Obaya, Á. J., Adachi, S., & Sedivy, J. M. (1997) · PubMed · Cited by 443
Genetic Interactions in Cancer Progression and Treatment
Ashworth, A., Lord, C. J., & Reis-Filho, J. S. (2011) · Cell · doi:10.1016/j.cell.2011.03.020 · Cited by 426
“between oncogenes, such as the transcription factor gene MYC and the GTPase gene RAS, have long been recognized as contributing to the processes of transformation and immortalization (Land et al., 1983).”
Mitotic chromosomal instability and cancer: mouse modelling of the human disease
Schvartzman, J.-M., Sotillo, R., & Benezra, R. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2781 · Cited by 414
“Transformation of cells in culture has been a standard assay to determine the oncogenic or tumour suppressive nature of a gene for more than two decade”
Elgendy, M., Sheridan, C., Brumatti, G., & Martin, S. J. (2011) · Molecular Cell · doi:10.1016/j.molcel.2011.02.009 · Cited by 426
“Deregulated oncogenes such asMYC, RAS, and BRAF can increase rates of cellular proliferation, but typically require cooperating oncogenes or inactivation of tumor suppressor genes such as P53 or RB to fully transform cells (Land et al., 1983; Serrano et al., 1997).”
BackgroundRas -Transformed Cells: Altered Levels of Phosphatidylinositol-4,5-Bisphosphate and Catabolites
Fleischman, L. F., Chahwala, S. B., & Cantley, L. (1986) · Science · doi:10.1126/science.3001936 · Cited by 439
Leder, A., Pattengale, P. K., Kuo, A., Stewart, T. A., & Leder, P. (1986) · Cell · doi:10.1016/0092-8674(86)90280-1 · Cited by 423
D'Cruz, C. M., Gunther, E. J., Boxer, R. B., Hartman, J. L., Sintasath, L., Moody, S. E., Cox, J. D., Ha, S. I., Belka, G. K., Golant, A., et al. (2001) · Nature Medicine · doi:10.1038/84691 · Cited by 418
“The observation that coexpression of c-MYC and Hras1 can accelerate malignant transformation in vitro and in vivo constituted an early demonstration of synergy between oncogenic pathway”
BackgroundMechanisms of Oncogene-Induced Replication Stress: Jigsaw Falling into Place
Kotsantis, P., Petermann, E., & Boulton, S. J. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1461 · Cited by 416
Independent and synergistic activity of rol A, B and C loci in stimulating abnormal growth in plants
Spena, A., Schmülling, T., Koncz, C., & Schell, J. S. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02729.x · Cited by 416
Cyclin D1/bcl-1 cooperates with myc genes in the generation of B-cell lymphoma in transgenic mice.
Lovec, H., Grzeschiczek, A., Kowalski, M. B., & Möröy, T. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06655.x · Cited by 410
Greenberg, R. A., O'Hagan, R. C., Deng, H., Xiao, Q., Hann, S. R., Adams, R. R., Lichtsteiner, S., Chin, L., Morin, G. B., & DePinho, R. A. (1999) · Oncogene · doi:10.1038/sj.onc.1202669 · Cited by 411
“…average of 34 foci per 10 cm plate (Figure 6, Myc+RAS); while Ras alone generated between 0 and 3 foci per plate (Figure 6, RAS+pBABE), consistent with previous ®ndings that an immortalizing agent and activated RAS are required for e cient transformation of primary rodent cells (Land et al., 1983).”
ResultWolf, D., & Rotter, V (1985) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.82.3.790 · Cited by 410
Bernard, O., Cory, S., Gerondakis, S., Webb, E., & Adams, J. M. (1983) · The EMBO Journal · doi:10.1002/j.1460-2075.1983.tb01749.x · Cited by 426
Cooperative effects of INK4a and ras in melanoma susceptibility in vivo
Chin, L., Pomerantz, J., Polsky, D., Jacobson, M., Cohen, C., Cordon-Cardo, C., Horner, J. W., & DePinho, R. A. (1997) · Genes & Development · doi:10.1101/gad.11.21.2822 · Cited by 402
“, myc overexpression (Land et al. 1983), loss of ink4a or p53 function (Serrano et al.”
BackgroundXu, J., Chen, Y., & Olopade, O. I. (2010) · Genes & Cancer · doi:10.1177/1947601910378691 · Cited by 382
Ray, R. B., Lagging, L. M., Meyer, K., & Ray, R. (1996) · Journal of Virology · doi:10.1128/jvi.70.7.4438-4443.1996 · Cited by 403
Serasinghe, M. N., Wieder, S. Y., Renault, T. T., Elkholi, R., Asciolla, J. J., Yao, J. L., Jabado, O., Hoehn, K., Kageyama, Y., Sesaki, H., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.01.003 · Cited by 389
“…fibroblasts (MEFs) infected with E1A and the oncogenic form of RAS (RASG12V) undergo rapid immortalization and transformation, which is defined by avoidance of the Hayflick limit, clonogenic survival, and the loss of contact inhibition (Hanahan and Weinberg, 2011; Land et al., 1983; Ruley, 1983).”
BackgroundDrebin, J. A., Link, V. C., Stern, D. F., Weinberg, R. A., & Greene, M. I. (1985) · Cell · doi:10.1016/s0092-8674(85)80050-7 · Cited by 400
Self-citationMany roads lead to oncogene-induced senescence
Courtois-Cox, S., Jones, S. L., & Cichowski, K. (2008) · Oncogene · doi:10.1038/sj.onc.1210950 · Cited by 397
“However, even at this time, additional cooperating genetic alterations were known to be required for Ras to transform primary cells (Land et al., 1983).”
BackgroundPietenpol, J. A., Holt, J. T., Stein, R. W., & Moses, H. L. (1990) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.87.10.3758 · Cited by 398
JNK‐ and Fos‐regulated Mmp1 expression cooperates with Ras to induce invasive tumors in Drosophila
Uhlirova, M., & Bohmann, D. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601401 · Cited by 395
“The complexity of such oncogenic programming explains why in order for a malignant tumor to arise, multiple cooperating oncogenic mutations have to occur (Land et al, 1983).”
BackgroundWeissman, B. E., Saxon, P. J., Pasquale, S. R., Jones, G. R., Geiser, A. G., & Stanbridge, E. J. (1987) · Science · doi:10.1126/science.3031816 · Cited by 396
Polypeptide Growth Factors: Roles in Normal and Abnormal Cell Growth
Deuel, T. F. (1987) · Annual Review of Cell Biology · doi:10.1146/annurev.cb.03.110187.002303 · Cited by 356
Function of the c-Myc Oncogenic Transcription Factor
Dang, C. V., Resar, L. M. S., Emison, E., Kim, S., Li, Q., Prescott, J. E., Wonsey, D., & Zeller, K. (1999) · Experimental Cell Research · doi:10.1006/excr.1999.4686 · Cited by 379
BIN1 is a novel MYC–interacting protein with features of a tumour suppressor
Sakamuro, D., Elliott, K. J., Wechsler-Reya, R., & Prendergast, G. C. (1996) · Nature Genetics · doi:10.1038/ng0996-69 · Cited by 387
Oncogene Activation in Chemical Carcinogenesis
(1988) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60222-5 · Cited by 388
Doyle, A., Martin, W. J., Funa, K., Gazdar, A., Carney, D., Martin, S. E., Linnoila, I., Cuttitta, F., Mulshine, J., & Bunn, P. (1985) · The Journal of experimental medicine · doi:10.1084/jem.161.5.1135 · Cited by 382
The molecular role of Myc in growth and transformation: recent discoveries lead to new insights
Facchini, L. M., & Penn, L. Z. (1998) · The FASEB Journal · doi:10.1096/fasebj.12.9.633 · Cited by 377
“In primary rat embryo fibroblasts and hematopoietic cells, constitutive expression of c-myc, along with a cooperating oncogene such as ras or vabl, results in malignant transformation (48, 49).”
BackgroundThe integration of molecular genetics into cancer management
Weinberg, R. A. (1992) · Cancer · doi:10.1002/1097-0142(19920915)70:4+<1701::aid-cncr2820701609>3.0.co;2-s · Cited by 31
Genetic alterations in the adenoma–carcinoma sequence
Cho, K. R., & Vogelstein, B. (1992) · Cancer · doi:10.1002/1097-0142(19920915)70:4+<1727::aid-cncr2820701613>3.0.co;2-p · Cited by 381
Harlow, E., Franza, B. R., & Schley, C. (1985) · Journal of Virology · doi:10.1128/jvi.55.3.533-546.1985 · Cited by 381
MOLECULAR MECHANISMS OF ULTRAVIOLET RADIATION CARCINOGENESIS
Ananthaswamy, H. N., & Pierceall, W. E. (1990) · Photochemistry and Photobiology · doi:10.1111/j.1751-1097.1990.tb08452.x · Cited by 372
Inhibition of Ras-Induced Proliferation and Cellular Transformation by p16 INK4
Serrano, M., Gómez-Lahoz, E., DePinho, R. A., Beach, D., & Bar-Sagi, D. (1995) · Science · doi:10.1126/science.7809631 · Cited by 373
Oncogene-Induced Cell Senescence — Halting on the Road to Cancer
Mooi, W. J., & Peeper, D. S. (2006) · New England Journal of Medicine · doi:10.1056/nejmra062285 · Cited by 371
The gene for human p53 cellular tumor antigen is located on chromosome 17 short arm (17p13).
McBride, O. W., Merry, D., & Givol, D. (1986) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.83.1.130 · Cited by 365
Cellular transformation by coordinated action of three peptide growth factors from human platelets
Assoian, R. K., Grotendorst, G. R., Miller, D. M., & Sporn, M. B. (1984) · Nature · doi:10.1038/309804a0 · Cited by 375
Association of adenovirus early-region 1A proteins with cellular polypeptides.
Harlow, E., Whyte, P., Franza, B. R., & Schley, C. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.5.1579 · Cited by 369
Viral carcinogenesis: revelation of molecular mechanisms and etiology of human disease
Butel, J. S. (2000) · Carcinogenesis · doi:10.1093/carcin/21.3.405 · Cited by 371
Ryder, E. F., Snyder, E. Y., & Cepko, C. L. (1990) · Journal of Neurobiology · doi:10.1002/neu.480210209 · Cited by 367
Schreiber-Agus, N., Chin, L., Chen, K., Torres, R., Rao, G., Guida, P., Skoultchi, A. I., & DePinho, R. A. (1995) · Cell · doi:10.1016/0092-8674(95)90356-9 · Cited by 364
Cancer stem cells – old concepts, new insights
Vermeulen, L., Sprick, M. R., Kemper, K., Stassi, G., & Medema, J. P. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.20 · Cited by 352
Ectopic Expression of the Serotonin 1c Receptor and the Triggering of Malignant Transformation
Julius, D., Livelli, T. J., Jessell, T. M., & Axel, R. (1989) · Science · doi:10.1126/science.2727693 · Cited by 359
Cell cycle arrest mediated by the MEK/mitogen-activated protein kinase pathway
Pumiglia, K. M., & Decker, S. J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.2.448 · Cited by 356
Fairbairn, L. J., Cowling, G. J., Reipert, B. M., & Dexter, T. M. (1993) · Cell · doi:10.1016/0092-8674(93)90462-y · Cited by 358
Multistage carcinogenesis induced by ras and myc oncogenes in a reconstituted organ
Thompson, T. C., Southgate, J., Kitchener, G., & Land, H. (1989) · Cell · doi:10.1016/0092-8674(89)90625-9 · Cited by 352
Self-citationThe role of chalcones in suppression of NF-κB-mediated inflammation and cancer
Yadav, V. R., Prasad, S., Sung, B., & Aggarwal, B. B. (2011) · International Immunopharmacology · doi:10.1016/j.intimp.2010.12.006 · Cited by 339
Telomeres: Cancer to Human Aging
Stewart, S. A., & Weinberg, R. A. (2006) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.22.010305.104518 · Cited by 334
“…complexity, early studies in murine and avian models suggested that cancer may be the result of only a few mutations, raising the possibility that many of the observed mutations in human cancer cells were not responsible for the transformed phenotype (Hanahan & Weinberg 2000, Land et al. 1983).”
BackgroundSelf-citationHuman papillomavirus type 16 DNA cooperates with activated ras in transforming primary cells
Matlashewski, G., Schneider, J., Banks, L., Jones, N., Murray, A., & Crawford, L. (1987) · The EMBO Journal · doi:10.1002/j.1460-2075.1987.tb02426.x · Cited by 258
Takehara, K., LeRoy, E. C., & Grotendorst, G. R. (1987) · Cell · doi:10.1016/0092-8674(87)90294-7 · Cited by 347
Oncogene Amplification in Tumor Cells
(1986) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60201-8 · Cited by 346
Signaling Networks That Link Cell Proliferation and Cell Fate
Sears, R. C., & Nevins, J. R. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r100063200 · Cited by 336
Characterization of the human p53 gene.
Lamb, P., & Crawford, L. (1986) · Molecular and Cellular Biology · doi:10.1128/mcb.6.5.1379 · Cited by 327
Activation Of Cellular Oncogenes in Hemopoietic Cells by Chromosome Translocation
(1986) · Advances in Cancer Research · doi:10.1016/s0065-230x(08)60200-6 · Cited by 343
Mateyak, M. K., Obaya, A. J., & Sedivy, J. M. (1999) · Molecular and Cellular Biology · doi:10.1128/mcb.19.7.4672 · Cited by 331
“The sources of antibodies were as follows: New England Biolabs, phospho-specific mitogen-activated protein kinase (MAPK) (9101S); Oncogene Research, p21 (Ab-5); Pharmingen, Rb (14001A); Santa Cruz, c-Fos (sc-52), cyclin D1 (sc-450), cyclin D3 (sc-182), cyclin E (sc-481), cyclin E (sc-198), cyclin A (sc-596), cyclin B1…”
BackgroundHuman telomeres are attached to the nuclear matrix.
de Lange, T. (1992) · The EMBO Journal · doi:10.1002/j.1460-2075.1992.tb05104.x · Cited by 333
Healing and Hurting: Molecular Mechanisms, Functions, and Pathologies of Cellular Senescence
Adams, P. D. (2009) · Molecular Cell · doi:10.1016/j.molcel.2009.09.021 · Cited by 326
Roux, F., Durieu‐Trautmann, O., Chaverot, N., Claire, M., Mailly, P., Bourre, J. ‐., Strosberg, A. D., & Couraud, P. ‐. (1994) · Journal of Cellular Physiology · doi:10.1002/jcp.1041590114 · Cited by 316
Neurotrophic protein S100 beta stimulates glial cell proliferation.
Selinfreund, R. H., Barger, S. W., Pledger, W. J., & Van Eldik, L. J. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.9.3554 · Cited by 323
Role of epidermal growth factor in carcinogenesis.
Stoscheck, C. M., & King, L. E. (1986) · PubMed · Cited by 354
Imperiale, M. J., Kao, H. T., Feldman, L. T., Nevins, J. R., & Strickland, S. (1984) · Molecular and Cellular Biology · doi:10.1128/mcb.4.5.867 · Cited by 325
“ments studying transforming genes (24, 32), it is possible that the formation of a tumor in an animal requires the constitutive expression of an ElA-like function.”
BackgroundCoffey, R. J., Bascom, C. C., Sipes, N. J., Graves-Deal, R., Weissman, B. E., & Moses, H. L. (1988) · Molecular and Cellular Biology · doi:10.1128/mcb.8.8.3088 · Cited by 322
“Digests of pBR322 plasmids of c-myc (exons 2 and 3) (19), c-fos (4), KC (1), and P2-microglobulin (27) were prepared, and the fragments were separated by electrophoresis on 1% agarose gels that contained a single continuous sample well.”
MethodPRAK Is Essential for ras-Induced Senescence and Tumor Suppression
Sun, P., Yoshizuka, N., New, L., Moser, B. A., Li, Y., Liao, R., Xie, C., Chen, J., Deng, Q., Yamout, M., et al. (2007) · Cell · doi:10.1016/j.cell.2006.11.050 · Cited by 321
E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo.
Beijersbergen, R. L., Kerkhoven, R. M., Zhu, L., Carlée, L., Voorhoeve, P. M., & Bernards, R. (1994) · Genes & Development · doi:10.1101/gad.8.22.2680 · Cited by 322
“1992) and have immortalizing activity when intro duced in primary rat embryo fibroblast (REF) cultures (Land et al. 1983; Ruley 1983).”
BackgroundMethodImmortalization of precursor cells from the mammalian CNS
Frederiksen, K., Jat, P. S., Valtz, N., Levy, D., & McKay, R. (1988) · Neuron · doi:10.1016/0896-6273(88)90175-4 · Cited by 321
Allen, L. F., Lefkowitz, R. J., Caron, M. G., & Cotecchia, S. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.24.11354 · Cited by 322
Watnick, R. S., Cheng, Y.-N., Rangarajan, A., Ince, T. A., & Weinberg, R. A. (2003) · Cancer Cell · doi:10.1016/s1535-6108(03)00030-8 · Cited by 318
Self-citationRetractedInositol lipids and cell proliferation
Berridge, M. J. (1987) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(87)90017-5 · Cited by 312
Jat, P. S., & Sharp, P. A. (1989) · Molecular and Cellular Biology · doi:10.1128/mcb.9.4.1672 · Cited by 317
“All establishment-type oncogenes can complement an activated ras oncogene in transformation (28, 46).”
BackgroundAnalysis of genomic targets reveals complex functions of MYC
Patel, J. H., Loboda, A. P., Showe, M. K., Showe, L. C., & McMahon, S. B. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1393 · Cited by 312
“Both in vitro and in vivo evidence has demonstrated that MYC overexpression confers a proliferative advantage to tumour cell”
Backgroundvan Golen, K. L., Wu, Z.-F., Qiao, X. T., Bao, L. W., & Merajver, S. D. (2000) · PubMed · Cited by 325
Li, L. H., Nerlov, C., Prendergast, G., MacGregor, D., & Ziff, E. B. (1994) · The EMBO Journal · doi:10.1002/j.1460-2075.1994.tb06724.x · Cited by 311
Signal transduction within the nucleus by mitogen-activated protein kinase.
Seth, A., Gonzalez, F. A., Gupta, S., Raden, D. L., & Davis, R. J. (1992) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)35834-4 · Cited by 315
An adenovirus E1a protein region required for transformation and transcriptional repression
Lillie, J. W., Green, M., & Green, M. R. (1986) · Cell · doi:10.1016/0092-8674(86)90704-x · Cited by 313
Kennedy, A. R. (1998) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(98)00010-2 · Cited by 305
Rustgi, A. K., Dyson, N., & Bernards, R. (1991) · Nature · doi:10.1038/352541a0 · Cited by 311
The somatic mutation theory of cancer: growing problems with the paradigm?
Soto, A. M., & Sonnenschein, C. (2004) · BioEssays · doi:10.1002/bies.20087 · Cited by 295
Metadata
- Authors
- Land, H., Parada, L. F., & Weinberg, R. A.
- Affiliations
- Whitehead Institute for Biomedical Research (US)
- Venue
- Nature
- Published
- 1983-08
- Volume
- 304
- Issue
- 5927
- Pages
- 596-602
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- OpenAlex
- W1989009382
- Cited by
- 2,804
- References
- 56
- Citations by year
- 2026: 8 · 2025: 13 · 2024: 22 · 2023: 15 · 2022: 17 · 2021: 24 · 2020: 22 · 2019: 36 · 2018: 17 · 2017: 23 · 2016: 24 · 2015: 39 · 2014: 27 · 2013: 30 · 2012: 37
- FWCI
- 96.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Protein Kinase Regulation and GTPase Signaling
- Health Sciences › Medicine › Oncology › Cancer-related Molecular Pathways
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and Retrovirus Studies
- Keywords
- embryonic fibroblasts, oncogene cooperation, oncogenic Ras, MYC gene, polyomavirus large T antigen, cell immortalization, transfection
- MeSH terms
- Animals, Antigens, Viral, Antigens, Viral, Tumor, Cell Line, Cell Transformation, Viral, Cells, Cultured, Fibroblasts, Gene Expression Regulation, Genes, Viral, Genetic Complementation Test, Oncogenes, Phenotype, Polyomavirus, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.